
AUTOLOGOUS EXOSOMES
Autologous exosomes for wound care — chronic and post-surgical wounds.
Autologous exosomes for wound care — chronic and post-surgical wounds.
Autologous exosomes for chronic & post-surgical wounds
Wound healing is one of the clinical fields where autologous exosome-rich plasma is applied. In chronic or post-surgical wounds, exosomes stimulate fibroblast proliferation, endothelial sprouting and keratinocyte migration. Their anti-inflammatory action helps re-establish balance in non-healing wounds.

Four mechanisms working together
Cellular Communication
Regulatory RNAs and proteins support cell survival, proliferation and differentiation, and promote neovascularisation in endothelial cells.
Growth-Factor Cooperation
PDGF, VEGF, TGF-β and IGF-1 attract cells to the injury site, stimulate matrix deposition and improve vascular supply.
Inflammation Resolution
Macrophage polarisation shifts away from IL-1β and TNF-α toward IL-10 and TGF-β.
Structural Remodelling
A temporary fibrin–exosome scaffold supports organised, vascularised tissue rather than fibrotic scar.
Laboratory and animal research
Diabetic wound model (Cao et al., iScience, 2023): exosomes from PRP carried PDGF-BB, VEGF and bFGF. In high-glucose conditions they protected skin fibroblasts, restored their growth and migration, and in diabetic rats increased collagen deposition, new blood vessel formation and wound closure, via the PDGF-BB/JAK2/STAT3 pathway.
Activation method (Rui et al., Cell Transplantation, 2021): the way platelets are activated changed both the number of exosomes released and their growth-factor content, and the growth factors were found mainly inside the exosomes.
These are pre-clinical studies in cells and animals, with laboratory-isolated exosomes rather than MyExo. Clinical decisions remain with the treating physician.
Cao W, et al. iScience. 2023;26:108236. doi:10.1016/j.isci.2023.108236 · Rui S, et al. Cell Transplant. 2021;30:1–13. doi:10.1177/09636897211017833
Why autologous matters
From the Patient's Own Blood
Donor-free, with no additives.
Prepared at the Point of Care
Physician-prepared, fresh, in the clinic.
Not a Cosmetic "Exosome"
Unlike cosmetic or plant-derived "exosome" products, which are typically topical and not interchangeable with human extracellular vesicles.
Bring MyExo to your wound-care practice.
For healthcare professionals. Product information provided by the manufacturer. Distributed by Bionics Medical in the UAE and Saudi Arabia.